Implantoplasty as Adjunct to Combined Surgical Therapy of Peri-Implantitis

Implantoplasty as Adjunct to Combined Surgical Therapy of Peri-Implantitis: A Randomized Clinical Trial

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06131567

Enrollment

Registered

2023-11-14

Start date

2021-11-01

Completion date

2024-11-30

Last updated

2024-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Brief summary

Implantoplasty entails polishing of the implant surface during the surgical therapy of peri-implantitis. Given the controversy behind implantoplasty as surface decontamination method in the treatment of peri-implantitis, the goal of this clinical trial is to assess the clinical resolution and radiographic bone gain in peri-implantitis sites treated by means of reconstructive therapy (Inteross® + autogenous bone, Sigmagraft, CA, USA) + implantoplasty in combined defects when compared to the extent of implantoplasty along the exposed implant surface upon the clinical resolution and radiographic bone gain in peri-implantitis sites treated by means of reconstructive therapy (Inteross® + autogenous bone, Sigmagraft, CA, USA).

Interventions

PROCEDUREImplantoplasty

Implantoplasty as surface decontamination method

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized clinical trials with paired number of subjects

Eligibility

Sex/Gender

MALE

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* All patients in age of 18 to 80, non-smokers * With no presence of systemic disease or medication known to alter bone metabolism, and partial or complete edentulous patients that have no active periodontal disease. * Peri-implantitis defined according to the EFP/AAP consensus meeting * Combined defect configuration

Exclusion criteria

* Pregnancy or lactation * History of or current smokers * Uncontrolled medical conditions, * Cement-retained restoration * Lacking keratinized mucosa (≤2mm) on the lingual or buccal implant sites.

Design outcomes

Primary

Measure	Time frame	Description
Rate of disease resolution	12 months after surgery	pocket depth \<6mm, no bleeding on probing, no suppuration, no progressive bone loss

Countries

Spain

Contacts

Primary ContactMamen Tome Rincon, DH

mtome@periocicom.com+34924203045

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026